UK-based Synergy Health goes to Steris Corporation for $1.9 billion
Tuesday, October 14, 2014
Global leader infection prevention, Steris Corporation and Synergy Health, plc quoted that Steris is initiating a "recommended offer" under the UK law to take over Synergy in a all cash and stock transaction in approximately about £19.50 ($31.35) per Synergy share, or a total of almost $1.9 billion, based on Steris''s closing stock price of $56.38 per share on October 10, 2014. The combined company will have approximately $2.6 billion in annual revenues from over 60 countries, approximately 14,000 employees, and will bring together geographically complementary businesses.
Synergy is a worldwide pioneer in outsourced disinfection for medical device manufacturers, hospitals and different businesses, situated in the United Kingdom (UK). The organization offers benefits that help their clients'' capability to enhance the quality and productivity of their activities, while decreasing danger to their patients and customers.
